The direct costs of drug-induced skin reactions

Objective The aim of the study was an assessment of direct costs of patients hospitalised for for skin adverse drug reactions during 2002–2012 in the Department of Dermatology at the Military Institute of Medicine (Ministry of Defence) in Warsaw. The analysis was carried out from the perspectives of...

Full description

Bibliographic Details
Main Authors: Nina Kiepurska, Elwira Paluchowska, Witold Owczarek, Monika Szkultecka – Dębek, Karina Jahnz-Różyk
Format: Article
Language:English
Published: Institute of Rural Health 2017-05-01
Series:Annals of Agricultural and Environmental Medicine
Subjects:
Online Access:http://www.journalssystem.com/aaem/The-direct-costs-of-drug-induced-skin-reactions,72543,0,2.html
_version_ 1818316681473163264
author Nina Kiepurska
Elwira Paluchowska
Witold Owczarek
Monika Szkultecka – Dębek
Karina Jahnz-Różyk
author_facet Nina Kiepurska
Elwira Paluchowska
Witold Owczarek
Monika Szkultecka – Dębek
Karina Jahnz-Różyk
author_sort Nina Kiepurska
collection DOAJ
description Objective The aim of the study was an assessment of direct costs of patients hospitalised for for skin adverse drug reactions during 2002–2012 in the Department of Dermatology at the Military Institute of Medicine (Ministry of Defence) in Warsaw. The analysis was carried out from the perspectives of the public payer and service provider. Material and Methods The retrospective study was carried out in a group of 164 adult patients due to skin adverse drug reactions. Analysis was based on data from patient medical records and medical orders which provided information on the used resources, including diagnostic tests, medical consultations, medicinal products, hospitalisation duration, together with cost estimation, regardless of the treatment being the cause of the skin reaction. Results According to the International Statistical Classification of Diseases and Related Health Problems(ICD) diagnosis and scores, assigned by the National Healthcare Fund, it has been estimated that patient hospitalisation at the Department of Dermatology for skin drug reaction incurred costs at the average amount of €717.00 per patient. The complex diagnostics and pharmacotherapy of the same group of patients generated costs for the hospital at the average amount of €680 per patient. Conclusions As a result of the analysis, the therapy for skin adverse drug effects generates significant costs, both for the payer and the service provider. Since the costs are comparable, it seems that the pricing of medical procedures by the public payer is adequate for the costs incurred by the medical service provider.
first_indexed 2024-12-13T09:25:18Z
format Article
id doaj.art-c39aa8c178c644eb8f6bdcbb86a6e800
institution Directory Open Access Journal
issn 1232-1966
1898-2263
language English
last_indexed 2024-12-13T09:25:18Z
publishDate 2017-05-01
publisher Institute of Rural Health
record_format Article
series Annals of Agricultural and Environmental Medicine
spelling doaj.art-c39aa8c178c644eb8f6bdcbb86a6e8002022-12-21T23:52:39ZengInstitute of Rural HealthAnnals of Agricultural and Environmental Medicine1232-19661898-22632017-05-0124219019310.5604/12321966.123516872543The direct costs of drug-induced skin reactionsNina Kiepurska0Elwira Paluchowska1Witold Owczarek2Monika Szkultecka – Dębek3Karina Jahnz-Różyk4Department of Dermatology, Military Institute of Medicine, Warsaw, PolandDepartment of Dermatology, Military Institute of Medicine, Warsaw, PolandDepartment of Dermatology, Military Institute of Medicine, Warsaw, PolandDepartment of Dermatology, Military Institute of Medicine, Warsaw, PolandDepartment of Immunology and Allergology, Military Institute of Medicine, Warsaw, PolandObjective The aim of the study was an assessment of direct costs of patients hospitalised for for skin adverse drug reactions during 2002–2012 in the Department of Dermatology at the Military Institute of Medicine (Ministry of Defence) in Warsaw. The analysis was carried out from the perspectives of the public payer and service provider. Material and Methods The retrospective study was carried out in a group of 164 adult patients due to skin adverse drug reactions. Analysis was based on data from patient medical records and medical orders which provided information on the used resources, including diagnostic tests, medical consultations, medicinal products, hospitalisation duration, together with cost estimation, regardless of the treatment being the cause of the skin reaction. Results According to the International Statistical Classification of Diseases and Related Health Problems(ICD) diagnosis and scores, assigned by the National Healthcare Fund, it has been estimated that patient hospitalisation at the Department of Dermatology for skin drug reaction incurred costs at the average amount of €717.00 per patient. The complex diagnostics and pharmacotherapy of the same group of patients generated costs for the hospital at the average amount of €680 per patient. Conclusions As a result of the analysis, the therapy for skin adverse drug effects generates significant costs, both for the payer and the service provider. Since the costs are comparable, it seems that the pricing of medical procedures by the public payer is adequate for the costs incurred by the medical service provider.http://www.journalssystem.com/aaem/The-direct-costs-of-drug-induced-skin-reactions,72543,0,2.htmladverse drug reactionsdirect costsICD 10JGPNational Health Fund
spellingShingle Nina Kiepurska
Elwira Paluchowska
Witold Owczarek
Monika Szkultecka – Dębek
Karina Jahnz-Różyk
The direct costs of drug-induced skin reactions
Annals of Agricultural and Environmental Medicine
adverse drug reactions
direct costs
ICD 10
JGP
National Health Fund
title The direct costs of drug-induced skin reactions
title_full The direct costs of drug-induced skin reactions
title_fullStr The direct costs of drug-induced skin reactions
title_full_unstemmed The direct costs of drug-induced skin reactions
title_short The direct costs of drug-induced skin reactions
title_sort direct costs of drug induced skin reactions
topic adverse drug reactions
direct costs
ICD 10
JGP
National Health Fund
url http://www.journalssystem.com/aaem/The-direct-costs-of-drug-induced-skin-reactions,72543,0,2.html
work_keys_str_mv AT ninakiepurska thedirectcostsofdruginducedskinreactions
AT elwirapaluchowska thedirectcostsofdruginducedskinreactions
AT witoldowczarek thedirectcostsofdruginducedskinreactions
AT monikaszkulteckadebek thedirectcostsofdruginducedskinreactions
AT karinajahnzrozyk thedirectcostsofdruginducedskinreactions
AT ninakiepurska directcostsofdruginducedskinreactions
AT elwirapaluchowska directcostsofdruginducedskinreactions
AT witoldowczarek directcostsofdruginducedskinreactions
AT monikaszkulteckadebek directcostsofdruginducedskinreactions
AT karinajahnzrozyk directcostsofdruginducedskinreactions